Relevance of Small Molecule Inhibitors in Advancing Cancer Therapeutics

To overcome the difficulties in cancer treatments, scientists have been developing different and regenerative alternative treatment options for several years. One of the promising approaches is personalized targeted therapy. Small molecule inhibitors and monoclonal antibodies are used in targeted therapy investigations. Like everything else, considering the complex structure of cancer, small molecule inhibitors and monoclonal antibodies also have their own pros and cons. In order to develop a promising and effective small molecule inhibitor, understanding the changes in the pathways during carcinogenesis is vital.